Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Only people at high and very high risk of cardiovascular events benefit from combination treatment with statins + ezetimibe and/or Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.
Fewer non-fatal myocardial infarctions and strokes occur with the combination treatment; according to current knowledge, survival will not be extended.
We consider potential therapeutic strategies [targeting the intestinal microbiota](brain://boh-qegVP0…